H-TMGFTAPRFPHY-NH2
Ref. 3D-PP42819
Unbestimmte Größe | Nachfragen |
Produktinformation
- NH2-Thr-Met-Gly-Phe-Thr-Ala-Pro-Arg-Phe-Pro-His-Tyr-amide
Peptide H-TMGFTAPRFPHY-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TMGFTAPRFPHY-NH2 include the following: Chemical functionalization of graphene enabled by phage displayed peptides Y Cui, SN Kim, SE Jones, LL Wissler, RR Naik - Nano , 2010 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/nl102564d Evolutionary screening of collagen-like peptides that nucleate hydroxyapatite crystals WJ Chung , KY Kwon, J Song, SW Lee - Langmuir, 2011 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/la104757g Peptide targeted lipid nanoparticles for anticancer drug delivery TR Pearce, K Shroff , E Kokkoli - Advanced materials, 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adma.201200832 Receptor mediated delivery systems for cancer therapeutics T Minko - Fundamentals and Applications of Controlled Release , 2011 - Springerhttps://link.springer.com/chapter/10.1007/978-1-4614-0881-9_12 Optimization and high-throughput screening of antimicrobial peptides SE Blondelle, K Lohner - Current pharmaceutical design, 2010 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2010/00000016/00000028/art00013 Multifunctional platinum-based nanoparticles for biomedical applications Q Cheng , Y Liu - Wiley Interdisciplinary Reviews , 2017 - Wiley Online Libraryhttps://wires.onlinelibrary.wiley.com/doi/abs/10.1002/wnan.1410 The state-of-play and future of platinum drugs MG Apps, EHY Choi - Endocrine-related , 2015 - ses.library.usyd.edu.auhttps://ses.library.usyd.edu.au/handle/2123/24426 Recent advances and strategies in tumor vasculature targeted nano-drug delivery systems M Ying, G Chen, W Lu - Current Pharmaceutical Design, 2015 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2015/00000021/00000022/art00003 Androgen control of lipid metabolism in prostate cancer: novel insights and future applications LM Butler , MM Centenera - Endocrine-related , 2016 - erc.bioscientifica.comhttps://erc.bioscientifica.com/view/journals/erc/23/5/R219.xml The mimic epitopes of Mycobacterium tuberculosis screened by phage display peptide library have serodiagnostic potential for tuberculosis L Wang, X Deng, H Liu, L Zhao, X You - FEMS Pathogens , 2016 - academic.oup.comhttps://academic.oup.com/femspd/article-abstract/74/8/ftw091/2632700 Tumor Targeting Potential of Lipid-Based Nano-Pharmaceuticals (LNPs) K Gupta, A Yavlovich, A Puri - The Potential Application , 2013 - World Scientifichttps://www.worldscientific.com/doi/abs/10.1142/9789814368674_0005 A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells J Mai , S Song , M Rui , D Liu, Q Ding, J Peng - Journal of Controlled , 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365909004349 Self-assembled peptide-based nanomaterials for biomedical imaging and therapy GB Qi , YJ Gao, L Wang, H Wang - Advanced Materials, 2018 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adma.201703444 Screening and analysis peptides that bind specifically to HPV 58 E7 protein FAN Jiu-song, Z Hong-bin, LIN Jie - Journal of Yunnan , 2011 - yndxxb.ynu.edu.cnhttp://www.yndxxb.ynu.edu.cn/yndxxbzrkxb/en/article/id/570 Phage display-derived inhibitor of the MurF cell wall enzyme as a lead compound for the development of novel antimicrobial agents C Paradis-Bleau, A Lloyd - Gacaâ°NOMIQUE , 2007 - dam-oclc.bac-lac.gc.cahttps://dam-oclc.bac-lac.gc.ca/download?is_thesis=1&oclc_number=1132168476&id=26710888-e3f4-4a19-b47c-54330ca2e838&fileName=24377.pdf#page=281 Phage display-derived inhibitor of the essential cell wall biosynthesis enzyme MurF C Paradis-Bleau, A Lloyd , F Sanschagrin, T Clarke - BMC biochemistry, 2008 - Springerhttps://link.springer.com/article/10.1186/1471-2091-9-33 MurF Ligase Inhibitors: An Overview of Antibacterial Activity A Singh, MA Azam - Letters in Drug Design & Discovery, 2023 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/lddd/2023/00000020/00000011/art00002
Chemische Eigenschaften
Technische Anfrage zu: 3D-PP42819 H-TMGFTAPRFPHY-NH2
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.